Page last updated: 2024-09-05

piboserod and rotigaptide

piboserod has been researched along with rotigaptide in 1 studies

Compound Research Comparison

Studies (piboserod)	Trials (piboserod)	Recent Studies (post-2010) (piboserod)	Studies (rotigaptide)	Trials (rotigaptide)	Recent Studies (post-2010) (rotigaptide)
119	5	53	46	3	12

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mace, LC; Murray, KT; Yang, Z	1

Reviews

1 review(s) available for piboserod and rotigaptide

Article	Year
Nonantiarrhythmic drug therapy for atrial fibrillation. Heart rhythm, 2007, Volume: 4, Issue:3 Suppl Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Calcium Channel Blockers; Connexins; Drugs, Investigational; Fatty Acids, Omega-3; Gap Junctions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mineralocorticoid Receptor Antagonists; Oligopeptides; Oxidative Stress; Receptors, Serotonin, 5-HT4; Renin-Angiotensin System; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists	2007

Article

Year

Nonantiarrhythmic drug therapy for atrial fibrillation.

Heart rhythm, 2007, Volume: 4, Issue:3 Suppl

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Calcium Channel Blockers; Connexins; Drugs, Investigational; Fatty Acids, Omega-3; Gap Junctions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mineralocorticoid Receptor Antagonists; Oligopeptides; Oxidative Stress; Receptors, Serotonin, 5-HT4; Renin-Angiotensin System; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists

2007